Adam Steele

Adam Steele is an experienced CMC Regulatory Affairs professional, currently serving as the Director of CMC Regulatory at AstraZeneca since 2018. Prior to this role, Adam worked as a Freelance CMC Regulatory Consultant at CMC Regulatory Services Limited from 2017 to 2018, and held various positions at Eli Lilly and Company, including Development Scientist - Manufacturing, Regulatory Associate, and Senior Manufacturing Scientist. Adam earned a Biochemistry degree with Upper Second Class Honours from Brunel University and completed a Master of Science in Biochemical Engineering with Distinction at University College London.